RecruitingNCT05440331

Morbidity and Mortality: Surgery and Standardized Transmission in Operating Room

Morbidity and Mortality in Operating Room: Surgery and Standardized Communication


Sponsor

Assistance Publique - Hôpitaux de Paris

Enrollment

1,120 participants

Start Date

Sep 8, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

The primary objective of the study is to evaluate the efficacy of standard handover with AnesList© between physician anesthesists in operating room, for a complete transmission for a patient, on the occurence of event as death, serious complications or rehospitalization in month of postoperative after major surgery.


Eligibility

Min Age: 18 Years

Inclusion Criteria8

  • Patient aged \> 18 years;
  • Patients with score ASA I-IV;
  • Requiring urgent or planned surgery;
  • Major surgery (duration of surgery \> 2 hours, requiring a hospital stay of at least 1 night): orthopedics, cardiac, vascular, thoracic, visceral, ENT, plastic surgery;
  • Handover between two anesthesists defined as a definitive relay between one physician anaesthesist and another in operating room;
  • Intensive care anesthesists and nurse anaesthetist working in investigator center during the study;
  • Affiliated to a social security system;
  • No-opposition to participating to the study.

Exclusion Criteria4

  • Transmission between physician anaesthesist and nurse anaesthetist;
  • Medical transmission occurs out of anesthesia care out of operating room;
  • Medical transmission occurs in transitory manner (for example: coffee time, lunch time);
  • Patients enrolled in an another ongoing study of surgical intervention.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERTraining with AnesList©

Training with AnesList© as tool


Locations(1)

Department of Anesthesia and Intensive Care - Ambroise Paré Hospital - APHP

Boulogne-Billancourt, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05440331


Related Trials